The Health Technology Assessment (HTA) Council releases its preliminary recommendation on the non-government financing of cerebrolysin in combination with rehabilitation or standard of care for the treatment of adults post-ischemic stroke through its non-inclusion in the Philippine National Formulary.
Appeals will be accepted from 17 March 2023 to 31 March 2023

Kindly see full advisory:
To keep updated on HTA news, visit our website:
Like and follow our FB page: